-
Bergenin Targets γδT17 Cells in Psoriasis
2026-08-28
A 2026 Phytomedicine study identifies a PPARγ–PROX1–fatty acid oxidation pathway through which bergenin suppresses pathogenic γδT17 cells and reduces psoriasiform inflammation. Its combination of animal modeling, metabolic analysis, protein-interaction assays, and chromatin measurements provides a mechanistic framework for evaluating selective IL-17A regulation in psoriasis.
-
DMG-PEG2000-NH2: From Linker to Assay Design
2026-08-27
DMG-PEG2000-NH2 is an NH2-PEG derivative for rational bioconjugation and lipid nanoparticle workflows. This article goes beyond formulation basics to connect linker chemistry, analytical controls, and the assay-design lessons of optimized sulfonamide research.
-
Trypsin for Protease-Controlled Cell Biology
2026-08-27
Trypsin is a serine protease whose value extends beyond routine protein digestion. This article explains how to use its cleavage specificity as an experimental control while connecting protease handling to cell biology, cartilage assay design, viral membrane fusion, wound healing research, and neurogenic inflammation study.
-
Biotin-tyramide (A8011): TSA Workflow Guide
2026-08-26
Biotin-tyramide is a biotinylation reagent for HRP-driven tyramide signal amplification when conventional IHC or ISH signals are too weak or poorly localized. This guide covers solvent handling, assay setup, controls, and troubleshooting for fixed-cell and tissue workflows; it is for research use only and not for diagnostic, medical, or unvalidated live-cell applications.
-
HyperFluor 488 Goat Anti-Mouse IgG Guide
2026-08-26
HyperFluor 488 Goat Anti-Mouse IgG is a fluorescently labeled secondary antibody for detecting mouse IgG in immunofluorescence, flow cytometry, and western blotting. Its H+L binding profile supports broad mouse immunoglobulin recognition, while the reference endothelial study illustrates how fluorescence-based protein localization can complement DNA-damage and vascularization assays.
-
Stable-Isotope UHPLC–MS/MS for Methylated Nucleosides
2026-08-25
Zhang, Zhang, and Wang developed a stable isotope-diluted UHPLC–ESI-MS/MS method for accurately measuring 12 purine ribonucleosides, including 10 methylated species such as 1-methyl Adenosine. Ammonium bicarbonate-assisted ionization, isomer-resolving chromatography, and methanol–SPE cleanup improved sensitivity for intracellular analysis and established a practical platform for RNA modification research and nucleoside biomarker discovery.
-
HA-LNP PTEN mRNA for Transdermal Melanoma Therapy
2026-08-25
A 2026 Journal of Controlled Release study developed hyaluronate-conjugated lipid nanoparticles containing PTEN mRNA for topical, transdermal melanoma immunotherapy. The HA-DMG formulation combined nanoparticle stabilization with CD44-directed targeting, enabling skin and tumor penetration, PTEN restoration, immunogenic cell death, tumor growth suppression, and immune activation in preclinical models.
-
Caspase-3/7 Inhibitor I: Applied Apoptosis Workflows
2026-08-24
Use Caspase-3/7 Inhibitor I as a reversible, cell-permeable perturbation to determine whether apoptosis depends on executioner caspases rather than simply measuring cell loss. This guide translates phase-specific Candida krusei findings into practical host-cell workflows, controls, washout experiments, and troubleshooting strategies.
-
FDA Library Screening Reveals MERS-CoV Inhibitors
2026-08-24
de Wilde and colleagues screened an FDA-approved compound library and identified four molecules, including Lopinavir, that inhibited MERS-CoV replication in cell culture. The study established a practical repurposing framework for emerging coronavirus research while emphasizing that cellular activity requires validation in animal models and clinical settings.
-
DiscoveryProbe Stem Cell Compound Library Plus
2026-08-23
Turn pathway breadth into an interpretable stem cell screening workflow with 280 curated bioactive compounds spanning self-renewal, differentiation, proliferation, and disease-relevant signaling. A high-content parasite stem-cell study shows how quantitative imaging and orthogonal validation can sharpen hit triage beyond morphology alone.
-
Cy3 Goat Anti-Human IgG (H+L) Antibody Workflow
2026-08-22
Build brighter, more reproducible human IgG readouts across immunofluorescence, tissue staining, flow cytometry, and ELISA. This practical workflow shows how to use a Cy3 conjugated secondary antibody while controlling background, photobleaching, species mismatch, and matrix effects.
-
Imatinib Hydrochloride: A Conformation-Aware Guide
2026-08-22
Imatinib hydrochloride is a versatile tool for dissecting v-Abl, c-Kit, and PDGFR signaling. This guide connects target inhibition with kinase-conformation biology to improve assay design in leukemia and gastrointestinal stromal tumor research.
-
Purmorphamine: Smo Signaling for Cell Fate
2026-08-21
Purmorphamine is a Smoothened agonist that converts Hedgehog pathway biology into a practical tool for studying osteogenic signaling, neural degeneration, and sensory regulation. This article explains how to interpret its potency, design cross-system assays, and avoid misleading conclusions from dose transfer.
-
Cucurbitacin I: A Causal STAT3 Assay Framework
2026-08-20
Cucurbitacin I, also known as JSI-124, can support a rigorous causal analysis of JAK2/STAT3 signaling in cancer models. This article presents a compartment-aware assay strategy inspired by human SAN-plexus assembloids, connecting molecular inhibition to invasion, apoptosis, and tumor growth inhibition in vivo.
-
Dual-Action Inhibitors Alter p38α Dephosphorylation
2026-08-20
A bioRxiv preprint reports that selected kinase inhibitors can do more than block p38α MAP kinase activity: they also accelerate WIP1-mediated dephosphorylation by stabilizing an activation-loop conformation that exposes the phospho-threonine. The structural and biochemical findings suggest a way to design inhibitors that combine catalytic inhibition with phosphatase-favorable target remodeling.